Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04476654|
Recruitment Status : Recruiting
First Posted : July 20, 2020
Last Update Posted : August 3, 2020
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer||Behavioral: YouTube Video Arm||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||70 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video|
|Actual Study Start Date :||June 8, 2020|
|Estimated Primary Completion Date :||December 31, 2023|
|Estimated Study Completion Date :||December 31, 2023|
No Intervention: Fact Sheet Arm
Komen print materials about genetic counseling and testing will be given to women.
Active Comparator: YouTube Video Arm
Participants in this arm will receive the culturally tailored video either via a Youtube link or a DVD.
Behavioral: YouTube Video Arm
Participants (n=25) will watch a 20 minute YouTube video that will describe the genetic counseling and testing process and risk/benefit information in a culturally relevant format. Participants will complete pre and post assessments. After the session, participants interested in pursuing genetic counseling and testing services will be referred to a patient navigator who will navigate participants to identified no cost or low cost services.
- Rate of genetic counseling and testing uptake. [ Time Frame: 3 months ]Our primary outcome will be for participants to receive genetic testing and counseling. Investigators will be able to see if participant has scheduled a genetic testing appointment within the VCU Health appointment system.
- Knowledge Scale - Genetic counseling and testing knowledge . [ Time Frame: Within one hour before the intervention and within one hour post-intervention. ]The investigators will test general knowledge about hereditary breast and ovarian cancer
- Self-efficacy Scale [ Time Frame: Within one hour before the intervention and within one hour post-intervention. ]The investigators will test self-efficacy in genetic counseling services.
- Emotional Ambivalence Scale [ Time Frame: Within one hour before the intervention and within one hour post-intervention. ]The investigators will test the emotional ambivalence about participating in genetic counseling services.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04476654
|Contact: Vanessa B Sheppard, PhDfirstname.lastname@example.org|
|Contact: Arnethea Sutton, PhDemail@example.com|
|United States, Virginia|
|Massey Cancer Center||Recruiting|
|Richmond, Virginia, United States, 23298|
|Contact: Vanessa B Sheppard, PhD 804-628-2700 firstname.lastname@example.org|
|Principal Investigator:||Vanessa Sheppard, PhD||Virginia Commonwealth University|